BARCLAYS PLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 37 filers reported holding SEELOS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$13,000
-96.7%
15,948
-93.3%
0.00%
Q4 2021$390,000
+302.1%
238,478
+494.0%
0.00%
Q3 2021$97,000
-38.2%
40,146
-32.6%
0.00%
Q2 2021$157,000
+3040.0%
59,608
+5860.8%
0.00%
Q1 2021$5,0001,000
+273.1%
0.00%
Q2 2020$0268
+26700.0%
0.00%
Q4 2019$010.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Uniplan Investment Counsel, Inc. 664,477$890,0000.05%
ARDSLEY ADVISORY PARTNERS LP 50,000$67,0000.01%
MYCIO WEALTH PARTNERS, LLC 30,500$41,0000.00%
Procyon Advisors, LLC 2,500$3,0000.00%
WealthPLAN Partners, LLC 20,000$16,0000.00%
Renaissance Technologies 1,118,623$1,499,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 308,794$412,0000.00%
BlackRock Inc. 404,056$541,0000.00%
TWO SIGMA SECURITIES, LLC 13,544$18,0000.00%
JPMORGAN CHASE & CO 16$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders